Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jyothsna Giri, Ann M Moyer, Suzette J Bielinski & Pedro J Caraballo. (2019) Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare. Pharmacogenomics and Personalized Medicine 12, pages 305-318.
Read now
Read now
Articles from other publishers (35)
Y. Libiad, Y. Bousliman, Y. Cherrah & S. Serragui. (2023) Individualisation du traitement antidépresseur : suivi thérapeutique pharmacologique et tests pharmacogénétiques. NPG Neurologie - Psychiatrie - Gériatrie.
Crossref
Crossref
Maren S. FragalaJeffrey A. ShamanRaymond A. LorenzSteven E. Goldberg. (2022) Role of Pharmacogenomics in Comprehensive Medication Management: Considerations for Employers. Population Health Management 25:6, pages 753-762.
Crossref
Crossref
Sarah A. Morris, Ashraf T. Alsaidi, Allison Verbyla, Adilen Cruz, Casey Macfarlane, Joseph Bauer & Jai N. Patel. (2022)
Cost Effectiveness of Pharmacogenetic Testing for Drugs with Clinical Pharmacogenetics Implementation Consortium (
CPIC
) Guidelines: A Systematic Review
. Clinical Pharmacology & Therapeutics 112:6, pages 1318-1328.
Crossref
Crossref
Emiliano Giardina & Stefania Zampatti. (2022) The Future of Pharmacogenomics Requires New Discoveries and Innovative Education. Genes 13:9, pages 1575.
Crossref
Crossref
David F. Kisor, David R. Bright, Thomas R. Smith & Kristin WiisanenThomas R. Smith. 2022. Pharmacogenomics: Foundations, Competencies, and the Pharmacists’ Patient Care Process, 2nd Edition. Pharmacogenomics: Foundations, Competencies, and the Pharmacists’ Patient Care Process, 2nd Edition.
Abdullah Al Maruf & Chad A. Bousman. (2022) Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic. Psychiatry and Clinical Neurosciences Reports 1:2.
Crossref
Crossref
Rustin D. Crutchley & Nicole Keuler. (2022) Sub-Analysis of CYP-GUIDES Data: Assessing the Prevalence and Impact of Drug-Gene Interactions in an Ethnically Diverse Cohort of Depressed Individuals. Frontiers in Pharmacology 13.
Crossref
Crossref
Stefania Zampatti & Emiliano Giardina. (2022) Bioinformatic tools are essential to integrating pharmacogenomics into clinical practice: lessons from neuropsychiatric disorders. Pharmacogenomics 23:4, pages 221-223.
Crossref
Crossref
Marco Calabrò, Chiara Fabbri, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Diego Albani, Gianluigi Forloni, Panagiotis Ferentinos, Dan Rujescu, Julien Mendlewicz, Diana De Ronchi, Alessandro Serretti & Concetta Crisafulli. (2022) Metabolizing status of CYP2C19 in response and side effects to medications for depression: Results from a naturalistic study. European Neuropsychopharmacology 56, pages 100-111.
Crossref
Crossref
Lara E. Murphy, Trehani M. Fonseka, Chad A. Bousman & Daniel J. Müller. (2021) Gene-drug pairings for antidepressants and antipsychotics: level of evidence and clinical application. Molecular Psychiatry 27:1, pages 593-605.
Crossref
Crossref
Alan Talevi & Carolina L. Bellera. 2022. The ADME Encyclopedia. The ADME Encyclopedia
781
786
.
E. Bothos, E. Ntoumou, K. Kelaidoni, D. Roukas, N. Drakoulis, M. Papasavva, F. A. Karakostis, P. Moulos & K. Karakostis. (2021) Clinical pharmacogenomics in action: design, assessment and implementation of a novel pharmacogenetic panel supporting drug selection for diseases of the central nervous system (CNS). Journal of Translational Medicine 19:1.
Crossref
Crossref
Kariofyllis Karamperis, Maria Koromina, Panagiotis Papantoniou, Maria Skokou, Filippos Kanellakis, Konstantinos Mitropoulos, Athanassios Vozikis, Daniel J. Müller, George P. Patrinos & Christina Mitropoulou. (2021) Economic evaluation in psychiatric pharmacogenomics: a systematic review. The Pharmacogenomics Journal 21:4, pages 533-541.
Crossref
Crossref
Erika L. Meaddough, Sara M. Sarasua, Tracy K. Fasolino & Christopher L. Farrell. (2021) The impact of pharmacogenetic testing in patients exposed to polypharmacy: a scoping review. The Pharmacogenomics Journal 21:4, pages 409-422.
Crossref
Crossref
Benjamin Laplace, Benjamin Calvet, Aurelie Lacroix, Stephane Mouchabac, Nicolas Picard, Murielle Girard & Eric Charles. (2021) Acceptability of Pharmacogenetic Testing among French Psychiatrists, a National Survey. Journal of Personalized Medicine 11:6, pages 446.
Crossref
Crossref
Mikayla Fan, Mark C. Yarema, Adrian Box, Stacey Hume, Katherine J. Aitchison & Chad A. Bousman. (2020) Identification of high-impact gene–drug pairs for pharmacogenetic testing in Alberta, Canada. Pharmacogenetics and Genomics 31:2, pages 29-39.
Crossref
Crossref
Chad A. Bousman, Susanne A. Bengesser, Katherine J. Aitchison, Azmeraw T. Amare, Harald Aschauer, Bernhard T. Baune, Bahareh Behroozi Asl, Jeffrey R. Bishop, Margit Burmeister, Boris Chaumette, Li-Shiun Chen, Zachary A. Cordner, Jürgen Deckert, Franziska Degenhardt, Lynn E. DeLisi, Lasse Folkersen, James L. Kennedy, Teri E. Klein, Joseph L. McClay, Francis J. McMahon, Richard Musil, Nancy L. Saccone, Katrin Sangkuhl, Robert M. Stowe, Ene-Choo Tan, Arun K. Tiwari, Clement C. Zai, Gwyneth Zai, Jianping Zhang, Andrea Gaedigk & Daniel J Müller. (2020) Review and Consensus on Pharmacogenomic Testing in
Psychiatry. Pharmacopsychiatry 54:01, pages 5-17.
Crossref
Crossref
Chiara Fabbri, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Diego Albani, Gianluigi Forloni, Panagiotis Ferentinos, Dan Rujescu, Julien Mendlewicz, Alessandro Serretti & Cathryn M. Lewis. (2021) Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression. Journal of Affective Disorders 279, pages 722-729.
Crossref
Crossref
Alan Talevi & Carolina L. Bellera. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
5
.
Gowtham Sathyanarayanan, Markus Haapala & Tiina Sikanen. (2020) Digital Microfluidics-Enabled Analysis of Individual Variation in Liver Cytochrome P450 Activity. Analytical Chemistry 92:21, pages 14693-14701.
Crossref
Crossref
Ron H. N. van Schaik, Daniel J. Müller, Alessandro Serretti & Magnus Ingelman-Sundberg. (2020) Pharmacogenetics in Psychiatry: An Update on Clinical Usability. Frontiers in Pharmacology 11.
Crossref
Crossref
Stavroula Siamoglou, Kariofyllis Karamperis, Christina Mitropoulou & George P Patrinos. (2020) Costing Methods as a Means to Measure the Costs of Pharmacogenomics Testing. The Journal of Applied Laboratory Medicine 5:5, pages 1005-1016.
Crossref
Crossref
Mohamed S Omer. (2020) Literature Review Concerning the Challenges of Implementing Pharmacogenetics in Primary Care Practice. Cureus.
Crossref
Crossref
Kevin T Bain, Calvin H Knowlton & Adriana Matos. (2020) Cost avoidance related to a pharmacist-led pharmacogenomics service for the Program of All-inclusive Care for the Elderly. Pharmacogenomics 21:10, pages 651-661.
Crossref
Crossref
Chiara Fabbri & Alessandro Serretti. (2020) Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future. Clinical Psychopharmacology and Neuroscience 18:1, pages 1-9.
Crossref
Crossref
Dragan Primorac, Lidija Bach-Rojecky, Dalia Vađunec, Alen Juginović, Katarina Žunić, Vid Matišić, Andrea Skelin, Borna Arsov, Luka Boban, Damir Erceg, Ivana Erceg Ivkošić, Vilim Molnar, Jasmina Ćatić, Ivan Mikula, Ljubica Boban, Lara Primorac, Bernard Esquivel & Morgan Donaldson. (2020) Pharmacogenomics at the center of precision medicine: challenges and perspective in an era of Big Data. Pharmacogenomics 21:2, pages 141-156.
Crossref
Crossref
David F. Kisor, David R. Bright, Thomas R. Smith & Kristin WiisanenDavid F. Kisor & Kristin Wiisanen. 2020. Pharmacogenomics: Foundations, Competencies, and the Pharmacists’ Patient Care Process. Pharmacogenomics: Foundations, Competencies, and the Pharmacists’ Patient Care Process.
David F. Kisor, David R. Bright, Thomas R. Smith & Kristin WiisanenThomas R. Smith. 2020. Pharmacogenomics: Foundations, Competencies, and the Pharmacists’ Patient Care Process. Pharmacogenomics: Foundations, Competencies, and the Pharmacists’ Patient Care Process.
Jonathan C.W. Liu, Ilona Gorbovskaya, Chad Bousman, Lisa C. Brown & Daniel J. Müller. 2020. Personalized Psychiatry. Personalized Psychiatry
449
457
.
Joanna M. Biernacka, Ahmed T. Ahmed, Balwinder Singh & Mark A. Frye. 2020. Personalized Psychiatry. Personalized Psychiatry
403
412
.
Kristi Krebs & Lili Milani. (2019) Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good. Human Genomics 13:1.
Crossref
Crossref
John F. Greden, Sagar V. Parikh, Anthony J. Rothschild, Michael E. Thase, Boadie W. Dunlop, Charles DeBattista, Charles R. Conway, Brent P. Forester, Francis M. Mondimore, Richard C. Shelton, Matthew Macaluso, James Li, Krystal Brown, Alexa Gilbert, Lindsey Burns, Michael R. Jablonski & Bryan Dechairo. (2019) Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study. Journal of Psychiatric Research 111, pages 59-67.
Crossref
Crossref
Stacey L. Aldrich, Ethan A. Poweleit, Cynthia A. Prows, Lisa J. Martin, Jeffrey R. Strawn & Laura B. Ramsey. (2019) Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders. Frontiers in Pharmacology 10.
Crossref
Crossref
G. P. Kostyuk, N. V. Zakharova, A. M. Reznik, E. I. Surkova & V. V. Ilinsky. (2019) Perspectives of the use of pharmacogenetic tests in neurology and psychiatry. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:9, pages 131.
Crossref
Crossref
Geoffrey S. Ginsburg & Susanne B. Haga. 2019. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics. Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics
21
45
.